Start the conversation
Agrobot is on a mission. Based in Oxnard, Calif., the privately held firm wants to use a 3D camera and robotics to identify and pick the ripest berries, without damage – something human pickers find difficult when they're working for hours on end.
Then there's 12 Sigma Technologies, a San Diego firm that's developing a system to sift through hundreds of medical images and create an "early warning system" for lung cancer – a deadly disease with a five-year survival rate of just 17%.
There's also Tempus, a Chicago-based venture that wants to assimilate a patient's genetic makeup and medical history to create "precision treatment" plans that maximize a person's health.
All three of these companies have one thing in common: Their projects all rely on artificial intelligence (AI), a new wave of technology that's set to have a $15.7 trillion impact on the global economy.
Right now, fast and robust graphics processors are the main power behind AI.
But there's a new advance in AI that could accelerate its adoption even as it revs up computer performance – and with good reason: This innovation operates at lightning speeds but just "sips" energy.
In fact, this "artificial" intelligence parallels the actual thinking pattern of the human brain.
Known as "neuromorphic computing," this type of AI-powered "neural network" will find use in computer vision and speech and pattern recognition. According to researcher Gartner Group, this could become the predominant type of AI computing by 2025.
In short, we're talking about game-changing innovation – one that's being driven by a new kind of chip.
One specific company has leaped to the forefront. It's a company whose shares are still trading at bargain levels.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.